Eventide Asset Management LLC Acquires 746,231 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Eventide Asset Management LLC raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 979.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 822,438 shares of the company's stock after buying an additional 746,231 shares during the quarter. Eventide Asset Management LLC owned about 0.69% of Privia Health Group worth $14,977,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new position in shares of Privia Health Group in the 2nd quarter valued at approximately $26,000. Nisa Investment Advisors LLC raised its stake in Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock valued at $31,000 after buying an additional 930 shares during the last quarter. GAMMA Investing LLC raised its stake in Privia Health Group by 98.7% during the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock valued at $31,000 after buying an additional 845 shares during the last quarter. Signaturefd LLC raised its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company's stock valued at $34,000 after buying an additional 626 shares during the last quarter. Finally, KBC Group NV raised its stake in Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after buying an additional 871 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. The trade was a 35.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Royal Bank of Canada reiterated an "outperform" rating and set a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Robert W. Baird boosted their price target on Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a research note on Monday, August 26th. Truist Financial boosted their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. KeyCorp assumed coverage on Privia Health Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $23.00 price target for the company. Finally, Barclays boosted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of $25.07.

Privia Health Group Stock Performance

PRVA opened at $21.66 on Friday. The business's 50-day simple moving average is $19.14 and its 200-day simple moving average is $18.65. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30. The stock has a market capitalization of $2.60 billion, a P/E ratio of 216.62, a price-to-earnings-growth ratio of 5.45 and a beta of 0.76.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.